CLINICAL TRIALS PROFILE FOR POLARAMINE
✉ Email this page to a colleague
All Clinical Trials for POLARAMINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02675374 ↗ | Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation | Completed | University Hospital, Bordeaux | Phase 3 | 2016-06-05 | This single-institution randomized controlled trial prospective will enrolled 48 patients scheduled for an aortic valve replacement. The objective of the present investigation is to determine the role of Polaramine® on reducing hemodynamic instability after separation from cardiopulmonary bypass (CPB) during cardiac surgery. Our hypothesis is that Polaramine® play an important role reducing dysfunction of the autonomic nervous system and hemodynamic stability after separation from CPB. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for POLARAMINE
Condition Name
Clinical Trial Locations for POLARAMINE
Clinical Trial Progress for POLARAMINE
Clinical Trial Phase
Clinical Trial Sponsors for POLARAMINE
Sponsor Name